Neurocrine Biosciences Inc
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 4,521 | 0.0% | 31,877 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 4,626 | 0.0% | 32,956 | 9/30/2025 |
| 2025 Q2 | 7/15/2025 | 4,112 | 0.0% | 32,717 | 6/30/2025 |
| 2025 Q1 | 5/14/2025 | 3,691 | 0.0% | 33,369 | 3/31/2025 |
| 2024 Q4 | 2/19/2025 | 5,531 | 0.0% | 40,518 | 12/31/2024 |
| 2024 Q3 | 11/15/2024 | 4,948 | 0.0% | 42,944 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 6,744 | 0.0% | 48,990 | 6/30/2024 |
| 2024 Q1 | 5/15/2024 | 6,613 | 0.0% | 47,947 | 3/31/2024 |
| 2023 Q4 | 2/16/2024 | 5,924 | 0.0% | 44,960 | 12/31/2023 |
| 2023 Q3 | 12/19/2023 | 4,445 | 0.0% | 39,511 | 9/30/2023 |
| 2023 Q2 | 12/19/2023 | 4,133 | 0.0% | 43,830 | 6/30/2023 |
| 2023 Q1 | 12/19/2023 | 4,825 | 0.0% | 47,666 | 3/31/2023 |
| 2022 Q4 | 12/19/2023 | 5,803 | 0.0% | 48,584 | 12/31/2022 |
| 2022 Q3 | 11/15/2022 | 5,052 | 0.0% | 47,564 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 4,600 | 0.0% | 47,190 | 6/30/2022 |
| 2022 Q1 | 5/16/2022 | 4,557 | 0.0% | 48,610 | 3/31/2022 |
| 2021 Q4 | 2/15/2022 | 4,283 | 0.0% | 50,290 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 5,008 | 0.0% | 52,216 | 9/30/2021 |
| 2021 Q2 | 8/16/2021 | 5,196 | 0.0% | 53,391 | 6/30/2021 |
| 2021 Q1 | 5/14/2021 | 4,807 | 0.0% | 49,427 | 3/31/2021 |
| 2020 Q4 | 2/12/2021 | 4,333 | 0.0% | 45,204 | 12/31/2020 |
| 2020 Q3 | 11/16/2020 | 3,507 | 0.0% | 36,473 | 9/30/2020 |
| 2020 Q2 | 8/17/2020 | 4,280 | 0.0% | 35,085 | 6/30/2020 |
| 2020 Q1 | 5/13/2020 | 3,068 | 0.0% | 35,453 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 3,314 | 0.0% | 30,833 | 12/31/2019 |